vanilmandelic acid has been researched along with Disease Exacerbation in 3 studies
Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The value of the tumour markers vanillylmandelic acid (VMA) and homovanillic acid (HVA) in urine (u) and serum (s), neurone-specific enolase (NSE), and lactate dehydrogenase (LDH) in the early prediction of relapse/progression in neuroblastoma is not known." | 3.72 | Tumour markers are poor predictors for relapse or progression in neuroblastoma. ( Berthold, F; Hero, B; Hunneman, DH; Simon, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydin, GB | 1 |
| Kutluk, MT | 1 |
| Yalcin, B | 1 |
| Varan, A | 1 |
| Akyuz, C | 1 |
| Buyukpamukcu, M | 1 |
| Simon, T | 1 |
| Hero, B | 1 |
| Hunneman, DH | 1 |
| Berthold, F | 1 |
| Yoneda, A | 1 |
| Oue, T | 1 |
| Imura, K | 1 |
| Inoue, M | 1 |
| Yagi, K | 1 |
| Kawa, K | 1 |
| Nishikawa, M | 1 |
| Morimoto, S | 1 |
| Nakayama, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PHASE III MULTICENTRE TRIAL OF TREATMENT OF NEUROBLASTOMA IN CHILDREN AND ADOLESCENTS[NCT00002802] | Phase 3 | 500 participants (Anticipated) | Interventional | 1990-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for vanilmandelic acid and Disease Exacerbation
| Article | Year |
|---|---|
The prognostic significance of vanillylmandellic acid in neuroblastoma.
Topics: Biomarkers, Tumor; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Female; Head | 2010 |
Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Topics: Adolescent; Biomarkers, Tumor; Bone Marrow Neoplasms; Child; Child, Preschool; Clinical Trials as To | 2003 |
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot study.
Topics: Adrenal Gland Neoplasms; Biomarkers, Tumor; Chemotherapy, Adjuvant; Disease Progression; Follow-Up S | 2001 |